1. Home
  2. AVR vs FACT Comparison

AVR vs FACT Comparison

Compare AVR & FACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVR
  • FACT
  • Stock Information
  • Founded
  • AVR 1999
  • FACT 2024
  • Country
  • AVR Australia
  • FACT United States
  • Employees
  • AVR N/A
  • FACT N/A
  • Industry
  • AVR
  • FACT
  • Sector
  • AVR
  • FACT
  • Exchange
  • AVR NYSE
  • FACT NYSE
  • Market Cap
  • AVR 241.5M
  • FACT 250.5M
  • IPO Year
  • AVR 2024
  • FACT 2024
  • Fundamental
  • Price
  • AVR $3.25
  • FACT $10.10
  • Analyst Decision
  • AVR Strong Buy
  • FACT
  • Analyst Count
  • AVR 4
  • FACT 0
  • Target Price
  • AVR $16.50
  • FACT N/A
  • AVG Volume (30 Days)
  • AVR 317.0K
  • FACT 98.5K
  • Earning Date
  • AVR 05-16-2025
  • FACT 01-01-0001
  • Dividend Yield
  • AVR N/A
  • FACT N/A
  • EPS Growth
  • AVR N/A
  • FACT N/A
  • EPS
  • AVR N/A
  • FACT N/A
  • Revenue
  • AVR $2,703,000.00
  • FACT N/A
  • Revenue This Year
  • AVR $29.52
  • FACT N/A
  • Revenue Next Year
  • AVR $204.83
  • FACT N/A
  • P/E Ratio
  • AVR N/A
  • FACT N/A
  • Revenue Growth
  • AVR N/A
  • FACT N/A
  • 52 Week Low
  • AVR $2.34
  • FACT $9.85
  • 52 Week High
  • AVR $8.79
  • FACT $10.32
  • Technical
  • Relative Strength Index (RSI)
  • AVR N/A
  • FACT N/A
  • Support Level
  • AVR N/A
  • FACT N/A
  • Resistance Level
  • AVR N/A
  • FACT N/A
  • Average True Range (ATR)
  • AVR 0.00
  • FACT 0.00
  • MACD
  • AVR 0.00
  • FACT 0.00
  • Stochastic Oscillator
  • AVR 0.00
  • FACT 0.00

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

About FACT FACT II ACQUISITION CORP

FACT II Acquisition Corp is a blank check company.

Share on Social Networks: